2025 Speakers

 

 

 

Ms Karin Agerman, CSO, CombiGene

Ms Karin Agerman | CSO | CombiGene » speaking at Advanced Therapies

Dr Roy Baynes, Senior Vice President Clinical Research, Eikon Therapeutics

Dr Roy Baynes | Senior Vice President Clinical Research | Eikon Therapeutics » speaking at Advanced Therapies

Dr. Niklas Beschorner, Head of Rnd, PROVIREX Genome Editing Therapies GmbH

Dr. Niklas Beschorner | Head of Rnd | PROVIREX Genome Editing Therapies GmbH » speaking at Advanced Therapies

Dr Jaap Boelens, Chief, Stem Cell Transplantation And Cellular Therapies Pediatrics, Memorial Sloan-Kettering Cancer Center

Dr Jaap Boelens | Chief, Stem Cell Transplantation And Cellular Therapies Pediatrics | Memorial Sloan-Kettering Cancer Center » speaking at Advanced Therapies

Fred Chereau, SVP, Strategy and Business Development, Alexion Pharmaceuticals

Fred Chereau | SVP, Strategy and Business Development | Alexion Pharmaceuticals » speaking at Advanced Therapies

Vicki Coutinho, Consultant, Geni Consulting

Vicki Coutinho | Consultant | Geni Consulting » speaking at Advanced Therapies

Mr Francesco Dazzi, Professor of Regenerative Medicine, King’s College London Executive & Medical Lead, Cell Therapy, astrazeneca

Mr Francesco Dazzi | Professor of Regenerative Medicine, King’s College London Executive & Medical Lead, Cell Therapy | astrazeneca » speaking at Advanced Therapies

Mr Victor Dillard, VP, Strategy & Operations, Resolution Therapeutics

Mr Victor Dillard | VP, Strategy & Operations | Resolution Therapeutics » speaking at Advanced Therapies

Marcus Droege, Senior Advisor, Market Access & Commercial, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs

Marcus Droege | Senior Advisor, Market Access & Commercial | EUCOPE - European Confederation of Pharmaceutical Entrepreneurs » speaking at Advanced Therapies

Ms Victoria English, Co-Founder And Editor, Evernow Publications

Ms Victoria English | Co-Founder And Editor | Evernow Publications » speaking at Advanced Therapies

Gregory Fiore, Chief Executive Officer, Exacis Biotherapeutics

Gregory Fiore | Chief Executive Officer | Exacis Biotherapeutics » speaking at Advanced Therapies

Katherine Forsey, Chief Research Officer, Charcot Marie Tooth Association

Katherine Forsey | Chief Research Officer | Charcot Marie Tooth Association » speaking at Advanced Therapies

Mr Miguel Forte, CEO, Kiji Tx

Mr Miguel Forte | CEO | Kiji Tx » speaking at Advanced Therapies

Dr Saba Ghassemi, Assistant Professor, University of Pennsylvania

Dr Saba Ghassemi | Assistant Professor | University of Pennsylvania » speaking at Advanced Therapies

Ms Uta Griesenbach, Professor, Molecular Medicine, National Heart And Lung Institute; President, British Society For Gene And Cell Therapy;, Imperial College London

Ms Uta Griesenbach | Professor, Molecular Medicine, National Heart And Lung Institute; President, British Society For Gene And Cell Therapy; | Imperial College London » speaking at Advanced Therapies

Mr Nagy Habib, Professor, Imperial College London

Mr Nagy Habib | Professor | Imperial College London » speaking at Advanced Therapies

Dr Patrick Hanley, Chief and Director, Cellular Therapy Program, Children's National Medical Center

Dr Patrick Hanley | Chief and Director, Cellular Therapy Program | Children's National Medical Center » speaking at Advanced Therapies

Ms Kathy Ivey, Vice President of Gene Therapy Research, Tenaya Therapeutics

Ms Kathy Ivey | Vice President of Gene Therapy Research | Tenaya Therapeutics » speaking at Advanced Therapies

Ron Jortner, Founder & Chief Executive Officer, Aspire Biosciences

Ron Jortner | Founder & Chief Executive Officer | Aspire Biosciences » speaking at Advanced Therapies

Mrs Margareth Jorvid, Head of Regulatory Affairs, Ilya Pharma

Mrs Margareth Jorvid | Head of Regulatory Affairs | Ilya Pharma » speaking at Advanced Therapies

Ms Angela Justice, Chief People Officer, Justice Group Advisors

Ms Angela Justice | Chief People Officer | Justice Group Advisors » speaking at Advanced Therapies

Dr Kilian Kelly, Chief Executive Officer & Managing Director, Cynata Therapeutics Ltd

Dr Kilian Kelly | Chief Executive Officer & Managing Director | Cynata Therapeutics Ltd » speaking at Advanced Therapies

Dr Sven Kili, Chief Development Officer, CCRM & Principal, CCRM

Dr Sven Kili | Chief Development Officer, CCRM & Principal | CCRM » speaking at Advanced Therapies

Bence Kozma, Research Assistant PostDoc, TU Wien

Bence Kozma | Research Assistant PostDoc | TU Wien » speaking at Advanced Therapies

Daniel Lewi, Co-founder & Chief Executive Officer, The Cure & Action for Tay-Sachs (CATS) Foundation

Daniel Lewi | Co-founder & Chief Executive Officer | The Cure & Action for Tay-Sachs (CATS) Foundation » speaking at Advanced Therapies

Pauline L'Hénaff, Head of Industry Engagement, Access to Medicine Foundation

Pauline L'Hénaff | Head of Industry Engagement | Access to Medicine Foundation » speaking at Advanced Therapies

Dr Alberto Malerba, Lecturer in Gene Therapy, royal holloway university of london

Dr Alberto Malerba | Lecturer in Gene Therapy | royal holloway university of london » speaking at Advanced Therapies

Julius Mathews, Project Manager & Research Fellow, Fraunhofer Institute for Production Technology IPT

Julius Mathews | Project Manager & Research Fellow | Fraunhofer Institute for Production Technology IPT » speaking at Advanced Therapies

Jo Miller, Director, Cell Therapy Sciences

Jo Miller | Director | Cell Therapy Sciences » speaking at Advanced Therapies

Dr Anji Miller, Skills Lead, Innovation Hubs for Gene Therapies/Director Translational Skills, LifeArc

Dr Anji Miller | Skills Lead, Innovation Hubs for Gene Therapies/Director Translational Skills | LifeArc » speaking at Advanced Therapies

Deana Mohr, Chief Executive Officer, MUVON Therapeutics

Deana Mohr | Chief Executive Officer | MUVON Therapeutics » speaking at Advanced Therapies

Paolo Morgese, Vice President, Public Affairs, Europe, Alliance for Regenerative Medicine

Paolo Morgese | Vice President, Public Affairs, Europe | Alliance for Regenerative Medicine » speaking at Advanced Therapies

Alexander Natz, Director General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs

Alexander Natz | Director General | EUCOPE - European Confederation of Pharmaceutical Entrepreneurs » speaking at Advanced Therapies

Mr Roberto Nitsch, Director, AstraZeneca

Mr Roberto Nitsch | Director | AstraZeneca » speaking at Advanced Therapies

Ms Nneka Onwudiwe, Former PRO/PE Regulatory Review Officer, Food and Drug Administration (FDA)

Ms Nneka Onwudiwe | Former PRO/PE Regulatory Review Officer | Food and Drug Administration (FDA) » speaking at Advanced Therapies

Kinnari Patel, President & COO, Rocket Pharma

Kinnari Patel | President & COO | Rocket Pharma » speaking at Advanced Therapies

Rik Patel, Senior Trade Manager, London & Partners

Rik Patel | Senior Trade Manager | London & Partners » speaking at Advanced Therapies

Dr Tom Payne, Chief Operating Officer, Laverock Therapeutics

Dr Tom Payne | Chief Operating Officer | Laverock Therapeutics » speaking at Advanced Therapies

Trine Pilgaard, Director, Head of Market Access, Denmark and Iceland, Pfizer

Trine Pilgaard | Director, Head of Market Access, Denmark and Iceland | Pfizer » speaking at Advanced Therapies

Ms Nicola Redfern, Director, NJ Redfern Ltd.

Ms Nicola Redfern | Director | NJ Redfern Ltd. » speaking at Advanced Therapies

Mr Sean Russell, Head of Translational Project Management & Regulatory Affairs, Telethon Foundation

Mr Sean Russell | Head of Translational Project Management & Regulatory Affairs | Telethon Foundation » speaking at Advanced Therapies

Mr Matthias Stöcker, Capability Lead, Boehringer-Ingelheim

Mr Matthias Stöcker | Capability Lead | Boehringer-Ingelheim » speaking at Advanced Therapies

Stephen Sullivan, COO, iPSirius

Stephen Sullivan | COO | iPSirius » speaking at Advanced Therapies

Dr Marina Tarunina, Research Director, Plasticell

Dr Marina Tarunina | Research Director | Plasticell » speaking at Advanced Therapies

Mr Stefanos Theoharis, Chief Executive Officer, OneChain Immunotherapeutics

Mr Stefanos Theoharis | Chief Executive Officer | OneChain Immunotherapeutics » speaking at Advanced Therapies

Dr. Marco Traub Marco Traub, Chief Executive Officer, Tesct—Society

Dr. Marco Traub Marco Traub | Chief Executive Officer | Tesct—Society » speaking at Advanced Therapies

Mr Ben Weil, Director of Manufacturing, INmune Bio

Mr Ben Weil | Director of Manufacturing | INmune Bio » speaking at Advanced Therapies

Anna Louisa Weltin, Research Fellow, Fraunhofer IPT

Anna Louisa Weltin | Research Fellow | Fraunhofer IPT » speaking at Advanced Therapies

Prof Darius Widera, Professor of Stem Cell Biology and Regenerative Medicine, University of Reading

Prof Darius Widera | Professor of Stem Cell Biology and Regenerative Medicine | University of Reading » speaking at Advanced Therapies

Mr Chris Williams, Chief Business Officer, Autolus Therapeutics

Mr Chris Williams | Chief Business Officer | Autolus Therapeutics » speaking at Advanced Therapies


Get Involved with Advanced Therapies Congress

 

To sponsor or exhibit

Ashlea Foster
ashlea.foster@terrapinn.com
+44 208 164 3032

 

To speak

Ila Dickinson
ila.dickinson@terrapinn.com
+44 207 092 1150